2013 Apr 15 Annual Report 2012 - Phosphagenics
2013 Apr 15 Annual Report 2012 - Phosphagenics
2013 Apr 15 Annual Report 2012 - Phosphagenics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Corporate Governance Statement continued<br />
The Companies corporate governance practices were in place throughout the year ended 31 December <strong>2012</strong>.<br />
Board functions<br />
The board seeks to identify the expectations of the shareholders, as well as other regulatory and ethical<br />
expectations and obligations. In addition, the board is responsible for identifying areas of signifi cant<br />
business risk and ensuring arrangements are in place to adequately manage those risks. To ensure<br />
that the board is well equipped to discharge its responsibilities it has established guidelines for the<br />
nomination and selection of directors and for the operation of the board. The responsibility for the<br />
operation and administration of the Group is delegated, by the board, to the Chief Executive Offi cer<br />
and the executive management team. The board ensures that this team is appropriately qualifi ed and<br />
experienced to discharge their responsibilities and has in place procedures to assess the performance<br />
of the Chief Executive Offi cer and the executive management team. Whilst at all times the board retains<br />
full responsibility for guiding and monitoring the Group, in discharging its stewardship it makes use of subcommittees.<br />
Specialist committees are able to focus on a particular responsibility and provide informed<br />
feedback to the board. To this end the board has established Share Allotment and Audit, Compliance<br />
and Corporate Governance Committees.<br />
The Directors in offi ce at the date of this statement, their skills, experience, expertise and period<br />
of directorship are detailed in the Directors’ <strong>Report</strong>. In respect of the attendance at Board and Committee<br />
Meetings, shareholders are referred to the table of Meeting Attendance contained on page 7.<br />
Structure of the Board<br />
The skills, experience and expertise relevant to the position of director held by each director in offi ce<br />
at the date of the annual report are included in the directors’ report. Directors of <strong>Phosphagenics</strong> Limited<br />
are considered to be independent when they are independent of management and free from any business<br />
or other relationship that could materially interfere with, or could reasonably be perceived to materially<br />
interfere with, the exercise of their unfettered and independent judgement.<br />
57<br />
In the context of director independence, “materiality” is considered from both the Group and individual<br />
director perspective. The determination of materiality requires consideration of both quantitative<br />
and qualitative elements. An item is presumed to be quantitatively immaterial if it is equal to or less than<br />
5% of the appropriate base amount. It is presumed to be material (unless there is qualitative evidence<br />
to the contrary) if it is equal to or greater than 10% of the appropriate base amount. Qualitative factors<br />
considered include whether a relationship is strategically important, the competitive landscape, the nature<br />
of the relationship and the contractual or other arrangements governing it and other factors that point<br />
to the actual ability of the director in question to shape the direction of the Group’s loyalty.<br />
In accordance with the defi nition of independence above, and the materiality thresholds set, the following<br />
directors of <strong>Phosphagenics</strong> Limited are considered to have the following status:<br />
Name Position and status Term in Office<br />
Non-executive directors<br />
Addison, J L Chairman and Independent Director 10 years<br />
Clarke, D Independent Director 2.5 years<br />
James, S Independent Director 2.5 years<br />
Webb, S Independent Director 2.5 years<br />
Executive directors<br />
Rosen, H President 13 years<br />
Ogru, E Chief Executive Offi cer 7 years<br />
The board recognises the Corporate Governance Council’s recommendation that the Chair should be an<br />
independent director.<br />
CORPORATE GOVERNANCE STATEMENT